About company
Vivendy Therapeutics Ltd. has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity - enhancing the efficacy of the therapy in MPS IVA significantly
- Unknown
- info@vivendy.ch
- Unknown
- www.vivendy.ch
- Not verified company
